Delivering Exceptional Medical Science Liaison Services to Key Stakeholders in the Marketplace

CHAPEL HILL, N.C., Nov. 22, 2011 /PRNewswire/ -- Medical Science Liaisons are the bridge between a company's science and critical stakeholders in the marketplace. Biopharmaceutical and medical device companies find it increasingly difficult to deliver exceptional MSL services to a diverse set of customers that include regional thought leaders, important clinical investigators, local opinion leaders, payer and government thought leaders, and various internal stakeholders.

"Medical Science Liaison Services Excellence: Generating Value for Diverse Customer Groups" provides benchmarks and insights across the many services and stakeholders that MSLs are involved with as part of their growing responsibilities.

For instance, 60 percent of study participants believe that managed care groups will be valuable users of MSL support services in the next two years. Thus, MSLs will need to understand how payer groups work and how best to serve internal constituents working with them. Currently, only about 30 percent of companies regularly support internal payer groups, according to the research.

Study topics include:

• Key Opinion Leaders Management
• MSL Internal Services and Activities
• MSL Services and Payer Education and Support
• MSL Services and Hospital/Health Care Access
• Emerging Trends and Mitigating Risks
• MSL Services and Physician Education
• MSL Services and Patient Education and Advocacy Support
• MSL Group Structure and Oversight
• MSL Activities Throughout Lifecycle

This study is based on research and information provided by 35 pharmaceutical and medical device executives from 30 companies. The 145-page report provides two segments: the total benchmark class and U.S. only.

Specifically, this primary research identifies valuable insights into MSL services structure as well as the roles and responsibilities of these services. The study offers powerful insights that you will be able to use in the organization and deployment of your MSLs. Additionally, the new report will provide information on how the roles of MSLs are evolving in the changing pharmaceutical environment and how regulatory concerns are affecting the MSL landscape.

To access the full report or to download a complimentary summary containing insights found in this report, click on the following link: http://www3.best-in-class.com/rr1133.htm.

ABOUT BEST PRACTICES, LLC

Best Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. For more information about Best Practices, LLC visit our Web site at www.best-in-class.com.

SOURCE Best Practices, LLC

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED